Author:
Barni S.,Petrelli F.,Cabiddu M.,Cazzaniga M.E.,Cremonesi M.
Reference17 articles.
1. Trastuzumab in the treatment of Breast Cancer;Hortobagyi;New Engl J Med,2005
2. A phase I/II dose-escalation trial of bevacizumab in previously treated metastatic breast cancer;Cobleigh;Semin Oncol,2003
3. Phase II combined biological therapy targeting the HER2 proto-oncogene and the vascular endothelial growth factor using trastuzumab (T) and bevacizumab (B) as first line treatment of HER2-amplified breast cancer;Pegram;Breast Cancer Res Treat,2006
4. Randomized phase III trial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breast cancer;Miller;J Clin Oncol,2005
5. North Central cancer treatment group (NCCTG) N0432: phase II trial of docetaxel with capecitabine and bevacizumab as first line chemotherapy for patients with metastatic breast cancer;Perez;Breast Cancer Res Treat,2006
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献